Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
Open Access
- 15 February 2001
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (4), 477-484
- https://doi.org/10.1172/jci11752
Abstract
Department of Defense Breast Cancer Program (Knutson). NIH grants, the National Cancer Institute (R01 CA75163), and the Department of Defense Breast Cancer Program (Dsis). NIH grant MO1-RR-00037.This publication has 43 references indexed in Scilit:
- CHARACTERIZATION OF CMVpp65-SPECIFIC CD8+ T LYMPHOCYTES USING MHC TETRAMERS IN KIDNEY TRANSPLANT PATIENTS AND HEALTHY PARTICIPANTS1Transplantation, 2000
- A Phase I Trial of an HLA-A1 Restricted MAGE-3 Epitope Peptide with Incomplete Freundʼs Adjuvant in Patients with Resected High-Risk MelanomaJournal of Immunotherapy, 1999
- Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytesEuropean Journal of Immunology, 1994
- Use of Helper T Cell-Inducing Peptides from Conserved Regions in HIV-1envin a Noncovalent Mixture with a CTL-Inducing V3-Loop Peptide forin VivoInduction of Long-Lasting Systemic CTL ResponseViral Immunology, 1994
- Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogeneCellular Immunology, 1993
- Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza a virus matrix proteinHuman Immunology, 1993
- A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.The Journal of Experimental Medicine, 1992
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.The Journal of Experimental Medicine, 1981